Position in ALNY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$734,479,783
-$90,665,658 QoQ
Shares Held
2,439,889
-2.2% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#12
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. ALNY ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $734,479,783 | 2,439,889 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $825,145,441 | 2,493,866 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,034,279,297 | 2,600,979 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $1,271,946,336 | 2,789,356 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $988,669,336 | 3,031,891 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $987,627,041 | 3,657,607 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $950,713,343 | 4,040,259 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,344,071,609 | 4,887,000 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $1,465,935,408 | 6,032,656 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $989,893,580 | 6,623,577 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,333,572,035 | 6,967,097 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $1,445,691,915 | 8,163,139 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,594,017,506 | 8,392,216 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $1,730,592,723 | 8,639,141 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $2,235,780,541 | 9,407,871 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $1,904,473,959 | 9,514,758 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $1,453,896,097 | 9,968,434 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,655,716,346 | 10,139,729 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,800,388,633 | 10,616,751 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,966,604,175 | 10,415,784 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $1,733,318,095 | 10,224,859 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $1,422,484,024 | 10,074,963 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $1,186,940,886 | 9,132,422 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,294,600,652 | 8,891,488 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,280,955,697 | 8,648,678 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $915,621,054 | 8,411,769 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||